Lymphatic and interstitial flow in the tumour microenvironment: Linking mechanobiology with immunity

Nature Reviews Cancer

Volumn 12, Issue 3, 2012, Pages 210-219

  Swartz, Melody A ^a   Lund, Amanda W ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

CANCER INVASION; CELL MIGRATION; FIBROBLAST; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INTERSTITIAL FLOW; LYMPH FLOW; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHATIC PARAMETERS; LYMPHATIC SYSTEM; METASTASIS; MODULATION; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; PRESSURE GRADIENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SENTINEL LYMPH NODE; SIGNAL TRANSDUCTION; STRESS; STROMA CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ANIMALS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MECHANOTRANSDUCTION, CELLULAR; NEOPLASMS; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84857556564     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3186     Document Type: Review

References (131)

1. Dafni, H., Israely, T., Bhujwalla, Z. M., Benjamin, L. E. & Neeman, M. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res. 62, 6731-6739 (2002).
2. Harrell, M. I., Iritani, B. M. & Ruddell, A. Tumorinduced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 170, 774-786 (2007).
3. Ruddell, A., Harrell, M. I. & Furuya, M. Sentinel lymph node lymphangiogenesis and increased lymph flow in murine tumor metastasis. Clin. Exp. Metast. 26, 883-884 (2009).
4. Pathak, A. P., Artemov, D., Neeman, M. & Bhujwalla, Z. M. Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype. Cancer Res. 66, 5151-5158 (2006).
5. Wiig, H., Tveit, E., Hultborn, R., Reed, R. K. & Weiss, L. Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scand. J. Clin. Lab. Invest. 42, 159-164 (1982).
6. Flessner, M. F., Choi, J., Credit, K., Deverkadra, R. & Henderson, K. Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clin. Cancer Res. 11, 3117-3125 (2005).
7. Pedersen, J. A., Boschetti, F. & Swartz, M. A. Effects of extracellular fiber architecture on cell membrane shear stress in a 3D fibrous matrix. J. Biomech. 40, 1484-1492 (2007).
8. Lammermann, T. & Sixt, M. The microanatomy of T-cell responses. Immunol. Rev. 221, 26-43 (2008).
9. Gretz, J. E., Norbury, C. C., Anderson, A. O., Proudfoot, A. E. & Shaw, S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192, 1425-1440 (2000).
10. Butler, T. P., Grantham, F. H. & Gullino, P. M. Bulk transfer of fluid in interstitial compartment of mammary tumors. Cancer Res. 35, 3084-3088 (1975).
11. Fukumura, D. & Jain, R. K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell. Biochem. 101, 937-949 (2007).
12. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
13. Dufort, C. C., Paszek, M. J. & Weaver, V. M. Balancing forces: architectural control of mechanotransduction. Nature Rev. Mol. Cell Biol. 12, 308-319 (2011).
14. Xu, R., Boudreau, A. & Bissell, M. Tissue architecture and function: dynamic reciprocity via extra-and intracellular matrices. Cancer Metastasis Rev. 28, 167-176 (2009).
15. Heldin, C. H., Rubin, K., Pietras, K. & Ostman, A. High interstitial fluid pressure - an obstacle in cancer therapy. Nature Rev. Cancer 4, 806-813 (2004).
16. Wiig, H. Evaluation of methodologies for measurement of interstitial fluid pressure (Pi): physiological implications of recent Pi data. Crit. Rev. Biomed. Eng. 18, 27-54 (1990).
17. Boucher, Y., Leunig, M. & Jain, R. K. Tumor angiogenesis and interstitial hypertension. Cancer Res. 56, 4264-4266 (1996).
18. Jain, R. K. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nature Rev. Cancer 8, 309-316 (2008).
19. Proulx, S. T. et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 70, 7053-7062 (2010).
20. + macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am. J. Pathol. 175, 1733-1745 (2009).
21. + macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659 (2009).
22. Flister, M. J. et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1. Blood 115, 418-429 (2009).
23. Xing, L. P. & Ji, R. C. Lymphangiogenesis, myeloid cells and inflammation. Exp. Rev. Clin. Immunol. 4, 599-613 (2008).
24. Halin, C., Tobler, N. E., Vigl, B., Brown, L. F. & Detmar, M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110, 3158-3167 (2007).
25. Tammela, T. & Alitalo, K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140, 460-476 (2010).
26. Paupert, J., Sounni, N. E. & Noel, A. Lymphangiogenesis in post-natal tissue remodeling: lymphatic endothelial cell connection with its environment. Mol. Aspects Med. 32, 146-158 (2011).
27. Avraamides, C. J., Garmy-Susini, B. & Varner, J. A. Integrins in angiogenesis and lymphangiogenesis. Nature Rev. Cancer 8, 604-617 (2008).
28. Skobe, M. et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159, 893-903 (2001).
29. Mumprecht, V. & Detmar, M. Lymphangiogenesis and cancer metastasis. J. Cell. Mol. Med. 13, 1405-1416 (2009).
30. Ruddell, A. et al. Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia 10, 706-713 (2008).
31. Kozlowski, H. & Hrabowska, M. Types of reaction in the regional lymph nodes in non-metastatic and minute-metastatic carcinoma of the uterine cervix. Arch. Geschwulstforsch. 45, 658-659 (1975).
32. Boardman, K. C. & Swartz, M. A. Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92, 801-808 (2003).
33. Ng, C. P., Helm, C. L. & Swartz, M. A. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68, 258-264 (2004).
34. Helm, C. E., Fleury, M. E., Zisch, A. H., Boschetti, F. & Swartz, M. A. Synergy between 3D flow and VEGF directs capillary morphogenesis in vitro: experiments and theoretical mechanisms. Proc. Natl Acad. Sci. USA 44, 15779-15784 (2005).
35. Wiig, H., Keskin, D. & Kalluri, R. Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function. Matrix Biol. 29, 645-656 (2010).
36. Schoppmann, S. F. et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161, 947-956 (2002).
37. Raju, B., Haug, S. R., Ibrahim, S. O. & Heyeraas, K. J. High interstitial fluid pressure in rat tongue cancer is related to increased lymph vessel area, tumor size, invasiveness and decreased body weight. J. Oral Pathol. Med. 37, 137-144 (2008).
38. Shieh, A., Rozansky, H., Hinz, B. & Swartz, M. A. Tumor cell invasion is promoted by interstitial flowinduced matrix priming by stromal fibroblasts. Cancer Res. 71, 790-800 (2011).
39. Shields, J. D. et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526-538 (2007).
40. Ng, C. P., Hinz, B. & Swartz, M. A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J. Cell Sci. 118, 4731-4739 (2005).
41. Polacheck, W. J., Charest, J. L. & Kamm, R. D. Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc. Natl Acad. Sci. USA 108, 11115-11120 (2011).
42. Chary, S. R. & Jain, R. K. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc. Natl Acad. Sci. USA 86, 5385-5389 (1989).
43. Winer, J. P., Oake, S. & Janmey, P. A. Non-linear elasticity of extracellular matrices enables contractile cells to communicate local position and orientation. PLoS ONE 4, e6382 (2009).
44. Wipff, P. J., Rifkin, D. B., Meister, J. J. & Hinz, B. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323 (2007).
45. Ahamed, J. et al. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-β1. Blood 112, 3650-3660 (2008).
46. Yu, H. M., Mouw, J. K. & Weaver, V. M. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 21, 47-56 (2011).
47. Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254 (2005).
48. Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11 (2008).
49. Ronnov-Jessen, L. & Bissell, M. J. Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol. Med. 15, 5-13 (2009).
50. Conklin, M. W. et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178, 1221-1232 (2011).
51. Finger, E. C. & Giaccia, A. J. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Met. Rev. 29, 285-293 (2010).
52. Guadall, A. et al. Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells. Frontiers Biosci. 3, 955-967 (2011).
53. Alcudia, J. F. et al. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase downregulation by pro-inflammatory cytokines. Frontiers Biosci. 13, 2721-2727 (2008).
54. Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906 (2009).
55. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392-401 (2006).
56. Goetz, J. G. et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146, 148-163 (2011).
57. Gaggioli, C. et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature Cell Biol. 9, 1392-1400 (2007).
58. Khalil, A. A. & Friedl, P. Determinants of leader cells in collective cell migration. Integr. Biol. 2, 568-574 (2010).
59. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).
60. Provenzano, P. P. et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38 (2006).
61. Friedl, P. & Gilmour, D. Collective cell migration in morphogenesis, regeneration and cancer. Nature Rev. Mol. Cell Biol. 10, 445-457 (2009).
62. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Trier, S. M. & Keely, P. J. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys. J. 95, 5374-5384 (2008).
63. Haessler, U., Teo, J. C., Foretay, D., Renaud, P. & Swartz, M. A. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr. Biol. 5 Dec. 2011 (doi:10.1039/C1IB00128K).
64. Qazi, H., Shi, Z. D. & Tarbell, J. M. Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression. PLoS ONE 6, e20348 (2011).
65. Shi, Z. D., Ji, X. Y., Qazi, H. & Tarbell, J. M. Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3D collagen I via upregulation of MMP-1. Am. J. Physiol. Heart Circ. Physiol. 297, H1225-H1234 (2009).
66. Denardo, D., Andreu, P. & Coussens, L. M. Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metast. Rev. 29, 309-316 (2010).
67. Munn, D. H. & Mellor, A. L. The tumor-draining lymph node as an immune-privileged site. Immunol. Rev. 213, 146-158 (2006).
68. + T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
69. Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475, 226-230 (2011).
70. Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M. & Swartz, M. A. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752 (2010).
71. + T-cell immune destruction. Trends Immunol. 30, 569-573 (2009).
72. Preynat-Seauve, O. et al. Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process. Cancer Res. 67, 5009-5016 (2007).
73. Gerlini, G. et al. Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. Clin. Immunol. 125, 184-193 (2007).
74. Battaglia, A. et al. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. Cancer Immunol. Immunother. 58, 1363-1373 (2009).
75. Mantovani, A., Romero, P., Palucka, A. & Marincola, F. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371, 771-783 (2008).
76. Bierie, B. & Moses, H. L. Transforming growth factor β (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev. 21, 49-59 (2010).
77. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Limon, P. The polarization of immune cells in the tumour environment by TGFβ. Nature Rev. Immunol. 10, 554-567 (2010).
78. Padua, D. & Massague, J. Roles of TGFβ in metastasis. Cell Res. 19, 89-102 (2009).
79. Wei, S. A. et al. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor β. Cancer Res. 68, 5432-5438 (2008).
80. Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol. 9, 162-174 (2009).
81. + myeloid cells that promote metastasis. Cancer Cell 13, 23-35 (2008).
82. + regulatory T cell proliferation. J. Exp. Med. 202, 919-929 (2005).
83. Tan, W. et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470, 548-553 (2011).
84. Forster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nature Rev. Immunol. 8, 362-371 (2008).
85. Miteva, D. O. et al. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ. Res. 106, 920-931 (2010).
86. Tomei, A. A., Siegert, S., Britschgi, M. R., Luther, S. A. & Swartz, M. A. Fluid flow regulates stromal cell organization and CCL21 expression in a tissueengineered lymph node microenvironment. J. Immunol. 183, 4273-4283 (2009).
87. Issa, A., Le, T. X., Shoushtari, A. N., Shields, J. D. & Swartz, M. A. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 69, 349-357 (2009).
88. Zhai, H. Y., Heppner, F. L. & Tsirka, S. E. Microglia/macrophages promote glioma progression. Glia 59, 472-485 (2011).
89. Machado, L. et al. Expression and function of T cell homing molecules in Hodgkin's lymphoma. Cancer Immunol. Immunother. 58, 85-94 (2009).
90. Raica, M., Cimpean, A. M. & Ribatti, D. The role of podoplanin in tumor progression and metastasis. Anticancer Res. 28, 2997-3006 (2008).
91. Kitano, H. et al. Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch. Pathol. Lab. Med. 134, 1520-1527 (2010).
92. Cueni, L. N. et al. Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am. J. Pathol. 177, 1004-1016 (2010).
93. Kawase, A. et al. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int. J. Cancer 123, 1053-1059 (2008).
94. Peduto, L. et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J. Immunol. 182, 5789-5799 (2009).
95. Ahrendt, M., Hammerschmidt, S. I., Pabst, O., Pabst, R. & Bode, U. Stromal cells confer lymph node-specific properties by shaping a unique microenvironment influencing local immune responses. J. Immunol. 181, 1898-1907 (2008).
96. + regulatory T cells. J. Exp. Med. 204, 735-745 (2007).
97. Yasuda, T. et al. Chemokines CCL19 and CCL21 promote activation-induced cell death of antigenresponding T cells. Blood 109, 449-456 (2007).
98. Davalos-Misslitz, A. C. et al. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 37, 613-622 (2007).
99. Hirakawa, S. et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010-1017 (2007).
100. Huggenberger, R. et al. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117, 4667-4678 (2011).
101. Von der Weid, P. Y., Rehal, S. & Ferraz, J. G. P. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27, 335-341 (2011).
102. Yin, N. et al. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 92, 25-30 (2011).
103. Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603-612 (2004).
104. Ling, S., Qi, C., Li, W., Xu, J. & Kuang, W. Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed. Clin. Exp. Ophthalmol. 37, 874-883 (2009).
105. Stuht, S. et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am. J. Transplant. 7, 377-384 (2007).
106. Angeli, V. et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24, 203-215 (2006).
107. Shrestha, B. et al. B cell-derived vascular endothelial growth factor α promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J. Immunol. 184, 4819-4826 (2010).
108. Kataru, R. P. et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34, 96-107 (2011).
109. Heller, F. et al. The contribution of B cells to renal interstitial inflammation. Am. J. Pathol. 170, 457-468 (2007).
110. Lee, Y. et al. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity 25, 499-509 (2006).
111. Thaunat, O., Kerjaschki, D. & Nicoletti, A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol. 27, 441-445 (2006).
112. Podgrabinska, S. et al. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J. Immunol. 183, 1767-1779 (2009).
113. Cohen, J. N. et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aireindependent direct antigen presentation. J. Exp. Med. 207, 681-688 (2010).
114. Sixt, M. et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19-29 (2005).
115. Junt, T. et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110-114 (2007).
116. Clement, C. C. et al. An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS ONE 5, e9863 (2010).
117. Batista, F. D. & Harwood, N. E. The who, how and where of antigen presentation to B cells. Nature Rev. Immunol. 9, 15-27 (2009).
118. Itano, A. A. & Jenkins, M. K. Antigen presentation to naive CD4 T cells in the lymph node. Nature Immunol. 4, 733-739 (2003).
119. Scheinecker, C., Mchugh, R., Shevach, E. M. & Germain, R. N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090 (2002).
120. Friedlaender, M. H., Baer, H. Immunologic Tolerance: role of the regional lymph node. Science 176, 312-314 (1972).
121. Munn, D. & Mellor, A. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117, 1147-1154 (2007).
122. Hood, J. L., San, R. S. & Wickline, S. A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801 (2011).
123. Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146 (2011).
124. Chaitanya, G. V. et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat. Res. Biol. 8, 155-164 (2010).
125. Liao, S. et al. Impaired lymphatic contraction associated with immunosuppression. Proc. Natl Acad. Sci. USA 108, 18784-18789 (2011).
126. Fletcher, A. L., Malhotra, D. & Turley, S. J. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol. 32, 12-18 (2011).
127. Fletcher, A. L. et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207, 689-697 (2010).
128. Lund, A. W. et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 23 Feb. 2012 (doi:10.1016/j.celrep. 2012.01.005).
129. Ng, C. P. & Swartz, M. A. Fibroblast alignment under interstitial fluid flow using a novel 3D tissue culture model. Am. J. Physiol. Heart Circ. Physiol. 284, H1771-H1777 (2003).
130. Roozendaal, R., Mebius, R. E. & Kraal, G. The conduit system of the lymph node. Int. Immunol. 20, 1483-1487 (2008).
131. Mebius, R. E., Streeter, P. R., Breve, J., Duijvestijn, A. M. & Kraal, G. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J. Cell Biol. 115, 85-95 (1991).